Immune-Onc Therapeutics
Developing a novel class of myeloid checkpoint inhibitors. Learn more
Launch date
Employees
Market cap
-
Enterprise valuation
€332m (Public information from Jan 2023)
Palo Alto California (HQ)
Authorizing premium user...